SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

First Financial Bankshares Inc. – ‘10-K’ for 12/31/22 – ‘EX-4’

On:  Wednesday, 2/22/23, at 7:34pm ET   ·   As of:  2/23/23   ·   For:  12/31/22   ·   Accession #:  950170-23-3864   ·   File #:  0-07674

Previous ‘10-K’:  ‘10-K’ on 2/22/22 for 12/31/21   ·   Next & Latest:  ‘10-K’ on 2/26/24 for 12/31/23   ·   20 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/23/23  First Financial Bankshares Inc.   10-K       12/31/22  116:49M                                    Donnelley … Solutions/FA

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML  12.92M 
 2: EX-4        Ex-4.2                                              HTML     47K 
 3: EX-21       Ex-21.1                                             HTML     40K 
 4: EX-23       Ex-23.1                                             HTML     35K 
 5: EX-31       Ex-31.1                                             HTML     39K 
 6: EX-31       Ex-31.2                                             HTML     39K 
 7: EX-32       Ex-32.1                                             HTML     37K 
 8: EX-32       Ex-32.2                                             HTML     37K 
14: R1          Document and Entity Information                     HTML    103K 
15: R2          Consolidated Balance Sheets                         HTML    128K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     45K 
17: R4          Consolidated Statements of Earnings                 HTML    148K 
18: R5          Consolidated Statements of Comprehensive Earnings   HTML     73K 
19: R6          Consolidated Statements of Shareholders' Equity     HTML    134K 
20: R7          Consolidated Statements of Shareholders' Equity     HTML     35K 
                (Parenthetical)                                                  
21: R8          Consolidated Statements of Cash Flows               HTML    138K 
22: R9          Summary of Significant Accounting Policies          HTML    204K 
23: R10         Securities                                          HTML    339K 
24: R11         Loans and Allowance for Credit Losses               HTML   4.26M 
25: R12         Loans Held for Sale                                 HTML     40K 
26: R13         Derivative Financial Instruments                    HTML     74K 
27: R14         Bank Premises and Equipment                         HTML     90K 
28: R15         Deposits and Borrowings                             HTML     81K 
29: R16         Line of Credit                                      HTML     46K 
30: R17         Income Taxes                                        HTML    169K 
31: R18         Fair Value Disclosures                              HTML    388K 
32: R19         Commitments and Contingencies                       HTML     40K 
33: R20         Financial Instruments with Off-Balance-Sheet Risk   HTML     54K 
34: R21         Concentration of Credit Risk                        HTML     36K 
35: R22         Employee Benefit Plans                              HTML     63K 
36: R23         Dividends from Subsidiaries                         HTML     36K 
37: R24         Regulatory Matters                                  HTML    292K 
38: R25         Stock Based Compensation                            HTML    352K 
39: R26         Condensed Financial Information - Parent Company    HTML    315K 
40: R27         Acquisitions                                        HTML     75K 
41: R28         Summary of Significant Accounting Policies          HTML    256K 
                (Policies)                                                       
42: R29         Summary of Significant Accounting Policies          HTML    100K 
                (Tables)                                                         
43: R30         Securities (Tables)                                 HTML    326K 
44: R31         Loans and Allowance for Credit Losses (Tables)      HTML   4.25M 
45: R32         Derivative Financial Instruments (Tables)           HTML     69K 
46: R33         Bank Premises and Equipment (Tables)                HTML     82K 
47: R34         Deposits and Borrowings (Tables)                    HTML     72K 
48: R35         Income Taxes (Tables)                               HTML    159K 
49: R36         Fair Value Disclosures (Tables)                     HTML    369K 
50: R37         Financial Instruments with Off-Balance-Sheet Risk   HTML     48K 
                (Tables)                                                         
51: R38         Regulatory Matters (Tables)                         HTML    276K 
52: R39         Stock Based Compensation (Tables)                   HTML    314K 
53: R40         Condensed Financial Information - Parent Company    HTML    318K 
                (Tables)                                                         
54: R41         Acquisitions (Tables)                               HTML     68K 
55: R42         Summary of Significant Accounting Policies -        HTML    107K 
                Additional Information (Detail)                                  
56: R43         Summary of Significant Accounting Policies -        HTML     67K 
                Computation of Basic EPS to Dilutive EPS (Detail)                
57: R44         Securities - Summary of Available-for-Sale          HTML     60K 
                Securities (Detail)                                              
58: R45         Securities - Additional Information (Detail)        HTML     61K 
59: R46         Securities - Amortized Cost and Estimated Fair      HTML     61K 
                Value of Available-for-Sale Securities (Detail)                  
60: R47         Securities - Continuous Unrealized-Loss Position    HTML     73K 
                of Available-for-Sale Securities (Detail)                        
61: R48         Loans And Allowance For Credit Losses - Loans       HTML     92K 
                Held-for-Investment by Portfolio Segment (Detail)                
62: R49         Loans And Allowance For Credit Losses - Additional  HTML     72K 
                Information (Detail)                                             
63: R50         Loans And Allowance For Credit Losses -             HTML     45K 
                Non-Accrual Loans, Loans Still Accruing and Past                 
                Due 90 Days or More and Restructured Loans                       
                (Detail)                                                         
64: R51         Loans And Allowance For Credit Losses- Non-Accrual  HTML     40K 
                Loans, Loans Still Accruing and Past Due 90 Days                 
                or More and Restructured Loans (Parenthetical)                   
                (Detail)                                                         
65: R52         Loans And Allowance For Credit Losses - Schedule    HTML     62K 
                of Non-Accrual Loans (Detail)                                    
66: R53         Loan And Allowance For Credit Losses - Changes in   HTML     78K 
                Allowance for Loan Losses (Detail)                               
67: R54         Loans And Allowance For Credit Losses - Schedule    HTML    123K 
                of loans that are individually evaluated for                     
                credit losses (Detail)                                           
68: R55         Loan And Allowance For Credit Losses - Schedule of  HTML     73K 
                Allowance for Loan Losses by Portfolio Segment                   
                (Detail)                                                         
69: R56         Loan And Allowance For Credit Losses - Schedule of  HTML     93K 
                Investment in Loans Related to Balance in                        
                Allowance for Loan Losses on Basis of Company's                  
                Impairment Methodology (Detail)                                  
70: R57         Loans And Allowance For Credit Losses - Schedule    HTML    180K 
                of Company's Internal Ratings of its Loans                       
                Held-for-Investment, Including The Year of                       
                Origination, by Portfolio Segments (Detail)                      
71: R58         Loans And Allowance For Credit Losses - Schedule    HTML    181K 
                of Past Due Loans (Detail)                                       
72: R59         Loans And Allowance For Credit Losses - Schedule    HTML     70K 
                of Loans Modified and Considered Troubled Debt                   
                Restructurings (Details)                                         
73: R60         Loans And Allowance For Credit Losses - Schedule    HTML     80K 
                of How Loans Were Modified as Troubled Debt                      
                Restructured Loans (Details)                                     
74: R61         Loans And Allowance For Credit Losses - Analysis    HTML     40K 
                of Changes in Loans to Officers, Directors,                      
                Principal Shareholders, or Associates of Such                    
                Persons (Detail)                                                 
75: R62         Loans Held for Sale - Additional Information        HTML     37K 
                (Detail)                                                         
76: R63         Derivative Financial Instruments - Summary of       HTML     47K 
                Outstanding Notional Balances and Fair Values of                 
                Outstanding Derivative Positions (Detail)                        
77: R64         Bank Premises and Equipment - Summary of Bank       HTML     67K 
                Premises and Equipment (Details)                                 
78: R65         Bank Premises and Equipment - Additional            HTML     38K 
                Information (Details)                                            
79: R66         Deposits and Borrowings - Additional Information    HTML     45K 
                (Details)                                                        
80: R67         Deposits and Borrowings - Scheduled Maturities of   HTML     48K 
                Time Deposits (Details)                                          
81: R68         Deposits and Borrowings - Schedule of Borrowings    HTML     43K 
                (Details)                                                        
82: R69         Line of Credit - Additional Information (Detail)    HTML     51K 
83: R70         Income Taxes - Additional Information (Detail)      HTML     58K 
84: R71         Income Taxes - Income Tax Expense (Detail)          HTML     45K 
85: R72         Income Taxes - Percentage of Pretax Earnings,       HTML     43K 
                Differs from Statutory Federal Income Tax Rate                   
                (Detail)                                                         
86: R73         Income Taxes - Schedule of Deferred Tax Assets and  HTML     61K 
                Liabilities (Detail)                                             
87: R74         Fair Value Disclosures - Additional Information     HTML     55K 
                (Detail)                                                         
88: R75         Fair Value Disclosures - Financial Assets and       HTML     88K 
                Financial Liabilities Measured at Fair Value on                  
                Recurring Basis (Detail)                                         
89: R76         Fair Value Disclosures - Summary of Loans           HTML     38K 
                Held-for-Sale at Fair Value (Detail)                             
90: R77         Fair Value Disclosures - Schedule of Gain Loss on   HTML     43K 
                Sale of Mortgage Loans (Detail)                                  
91: R78         Fair Value Disclosures - Schedule of Estimated      HTML     92K 
                Fair Values and Carrying Values of All Financial                 
                Instruments (Detail)                                             
92: R79         Commitments and Contingencies - Additional          HTML     43K 
                Information (Detail)                                             
93: R80         Financial Instruments with Off-Balance-Sheet Risk   HTML     34K 
                - Additional Information (Detail)                                
94: R81         Financial Instruments with Off-Balance-Sheet Risk   HTML     42K 
                - Schedule of Financial Instruments with                         
                Off-Balance-sheet Risk (Detail)                                  
95: R82         Employee Benefit Plans - Additional Information     HTML     77K 
                (Details)                                                        
96: R83         Dividends from Subsidiaries - Additional            HTML     35K 
                Information (Detail)                                             
97: R84         Regulatory Matters - Additional Information         HTML     55K 
                (Detail)                                                         
98: R85         Regulatory Matters - Schedule of Regulatory         HTML    105K 
                Capital Ratios Under the Basel III Regulatory                    
                Capital Framework (Detail)                                       
99: R86         Stock Based Compensation - Additional Information   HTML    117K 
                (Detail)                                                         
100: R87         Stock Based Compensation - Schedule of Changes in   HTML     68K  
                Restricted Stock Units (Details)                                 
101: R88         Stock Based Compensation - Summary of Vested and    HTML     55K  
                Unvested Restricted Stock Outstanding (Detail)                   
102: R89         Stock Based Compensation - Schedule of Analysis of  HTML     68K  
                Stock Option Activity (Detail)                                   
103: R90         Stock Based Compensation - Schedule of Information  HTML     67K  
                Concerning Outstanding and Vested Stock Options                  
                (Detail)                                                         
104: R91         Condensed Financial Information - Parent Company -  HTML    114K  
                Condensed Balance Sheets (Details)                               
105: R92         Condensed Financial Information - Parent Company -  HTML     75K  
                Condensed Statements of Earnings (Details)                       
106: R93         Condensed Financial Information - Parent Company -  HTML     99K  
                Condensed Statements of Cash Flows (Details)                     
107: R94         Cash Flow Information - Supplemental Information    HTML     43K  
                on Cash Flows and Noncash Transactions (Detail)                  
108: R95         Acquisitions - Additional Information (Detail)      HTML     46K  
109: R96         Acquisitions - Schedule of Amounts Recorded on      HTML     37K  
                Consolidated Balance Sheet on Acquisition Date                   
                (Detail)                                                         
110: R97         Acquisitions - Schedule of Amounts Recorded on      HTML     37K  
                Consolidated Balance Sheet on Acquisition Date                   
                (Detail) (Parenthentical)                                        
111: R98         Acquisitions - Schedule of Preliminary Estimated    HTML     63K  
                Fair Value Amounts Assigned to Major Asset and                   
                Liability Categories at Acquisition Date (Detail)                
114: XML         IDEA XML File -- Filing Summary                      XML    221K  
112: XML         XBRL Instance -- ffin-20221231_htm                   XML  15.38M  
113: EXCEL       IDEA Workbook of Financial Reports                  XLSX    276K  
13: EX-101.CAL  XBRL Calculations -- ffin-20221231_cal               XML    309K 
10: EX-101.DEF  XBRL Definitions -- ffin-20221231_def                XML   1.27M 
12: EX-101.LAB  XBRL Labels -- ffin-20221231_lab                     XML   2.18M 
 9: EX-101.PRE  XBRL Presentations -- ffin-20221231_pre              XML   1.82M 
11: EX-101.SCH  XBRL Schema -- ffin-20221231                         XSD    281K 
115: JSON        XBRL Instance as JSON Data -- MetaLinks              676±  1.16M  
116: ZIP         XBRL Zipped Folder -- 0000950170-23-003864-xbrl      Zip   1.56M  


‘EX-4’   —   Ex-4.2


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-4  

 

Exhibit 4.2

DESCRIPTION OF REGISTRANT’S SECURITIES

As of December 31, 2022, First Financial Bankshares, Inc. (the “Company,” “we,” or “our”) had one class of securities, our common stock, par value $0.01 per share (“common stock”), registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

DESCRIPTION OF COMMON STOCK

General

We are incorporated in the State of Texas. The rights of our shareholders are generally governed by Texas law and our Amended and Restated Certificate of Formation (the “certificate of formation”) and our Amended and Restated Bylaws, as amended (the bylaws). The terms of our common stock are therefore subject to Texas law, including the Texas Business Organizations Code (the “TBOC”), the common and constitutional law of Texas and federal law governing bank holding companies.

The following description of our common stock is a summary and is subject to, and is qualified in its entirety by reference to, the provisions of our certificate of formation and our bylaws. For more detailed information about the rights of our common stock, you should refer to our certificate of formation and bylaws and the applicable provisions of Texas law, including the TBOC, for additional information.

Authorized Capital Stock

We are authorized to issue 200,000,000 shares of common stock, par value $0.01 per share. All outstanding shares of our common stock are fully paid and non-assessable.

Voting Rights

Holders of our common stock are entitled to one vote per share in the election of directors and on all other matters submitted to a vote at a meeting of shareholders. No shareholder has the right of cumulative voting.

If a quorum exists, action on any matter, including the election of directors, shall be approved by the affirmative vote of a majority of the votes cast, unless our certificate of formation, bylaws or the TBOC require a greater number of affirmative votes. In the event that the number of director nominees exceeds the number of directors to be elected, the directors (not exceeding the authorized number of directors as fixed by the board of directors in accordance with our certificate of formation or bylaws) shall be elected by a plurality of the voting power of the shares entitled to vote who are present, in person or by proxy, at any such meeting and entitled to vote on the election of directors. Our bylaws provided that a majority of the votes cast means that the number of shares voted “for” a proposal, including the election of directors, must exceed the number of shares voted “against,” or “withheld” for, that proposal, and an abstention shall not constitute a vote cast.

No Preemptive or Similar Rights

Our common stock has no preemptive or conversion rights and is not entitled to the benefits of any redemption or sinking fund provision.

Dividend Rights

Holders of our common stock are entitled to dividends when, as and if declared by our board of directors out of funds legally available for dividends.

 


 

 

Liquidation Rights

In the event of our liquidation, the holders of our common stock will be entitled to share ratably in any distribution of our assets after payment of all debts and other liabilities.

Certain Business Combination Restrictions

We are subject to the affiliated business combinations provisions of Chapter 21, Subchapter M of the TBOC (Sections 21.601 through 21.610), which provide that a Texas corporation may not engage in certain business combinations, including mergers, consolidations and asset sales, with a person, or an affiliate or associate of such person, who is an “affiliated shareholder” (generally defined as the holder of 20% or more of the corporation’s voting shares) for a period of three years from the date such person became an affiliated shareholder unless: (1) the business combination or purchase or acquisition of shares made by the affiliated shareholder was approved by the board of directors of the corporation before the affiliated shareholder became an affiliated shareholder; or (2) the business combination was approved by the affirmative vote of the holders of at least two-thirds of the outstanding voting shares of the corporation not beneficially owned by the affiliated shareholder, at a meeting of shareholders called for that purpose (and not by written consent), not less than six months after the affiliated shareholder became an affiliated shareholder.

Certain Provisions of Our Certificate of Formation and Bylaws

Advance Notice for Shareholder Proposals and Director Nominations

Our bylaws contain provisions requiring that advance notice be delivered to the Company of any business to be brought by a shareholder before an annual meeting of shareholders and provide for certain procedures to be followed by shareholders in nominating candidates for election as directors. Generally, the advance notice provisions require that shareholder proposals be provided to us between 90 and 120 days prior to the first anniversary of the preceding year’s annual meeting and director nominations be provided to us between 120 and 150 days prior to the first anniversary of the preceding year’s annual meeting in order to be properly brought before a shareholder meeting. The notice must set forth specific information regarding the shareholder submitting the proposal or nomination and the proposal or director nominee, as described in our bylaws, and must otherwise comply with the terms of our bylaws. These requirements are in addition to those set forth in the regulations adopted by the SEC under the Exchange Act.

Special Meetings of Shareholders

Our bylaws provide that special meetings of our shareholders may be called for any purpose or purposes by (a) the Chairman of our board of directors joined by at least three members of the board of directors, or (b) a majority of our board of directors, and shall be called by the Chairman of the board of directors or Secretary at the request in writing of shareholders owning not less than twenty percent (20%) of our issued and outstanding shares entitled to vote at such meeting. Such request for a special meeting shall state the purpose or purposes of the proposed meeting, which purpose or purposes shall be stated in the notice of the meeting. Business transacted at any special meeting of shareholders shall be limited to the purposes stated in the notice. At a special meeting requested by our shareholders, only the Company and the shareholders who participated in the written meeting request may propose any item for consideration or nominate directors for election at such meeting.

Potential Anti-Takeover Effect

Certain provisions of our certificate of formation and bylaws could make the acquisition of control of our company and/or the removal of our existing management more difficult, including those that provide as follows:

 

 

 

cumulative voting in the election of our board of directors, which would otherwise allow less than a majority of shareholders to elect director candidates, is expressly denied under our certificate of formation and bylaws;

 

 


 

 

 

 

 

our bylaws limit the ability of shareholders to call a special meeting except in compliance with the procedures described above, which require shareholders owning not less than twenty percent (20%) of our issued and outstanding shares entitled to vote at such meeting to request a special meeting;

 

 

 

subject to certain limitations set forth in our bylaws, our board of directors fixes the size of the board of directors, may create new directorships and may appoint new directors to serve in such newly-created positions until the next election of one or more directors by our shareholders;

 

 

 

our bylaws may be altered, amended or repealed and new bylaws may be adopted by our board of directors, subject to repeal or change by action of the shareholders, at any meeting of the board of directors at which a quorum is present, provided notice of the proposed alteration, amendment, or repeal is contained in the notice of the meeting, unless (a) our certificate of formation or the TBOC wholly or partly reserves the power exclusively to our shareholders; or (b) in amending, repealing, or adopting a bylaw, the shareholders expressly provide that the board of directors may not amend, repeal, or readopt that bylaw; and

 

 

 

we have advance notice procedures with respect to shareholder proposals and the nomination of candidates for election as directors.

These provisions are expected to discourage coercive takeover practices and inadequate takeover bids. They are also designed, in part, to encourage persons seeking to acquire control of the Company to first negotiate with our board of directors. We believe that the benefits of increased protection give us the potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us and that these benefits outweigh the disadvantages of discouraging the proposals. Negotiating with the proponent could result in an improvement of the terms of the proposal.

Stock Exchange Listing

Our common stock is traded on the Nasdaq Global Select Market under the symbol “FFIN”.

Transfer Agent and Registrar

The transfer agent and registrar for our common stock is Continental Stock Transfer & Trust Company at 1 State Street, 30th Floor, New York, NY 10004-1561.

 

 



Dates Referenced Herein

This ‘10-K’ Filing    Date    Other Filings
Filed as of:2/23/23None on these Dates
Filed on:2/22/23
For Period end:12/31/22
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/06/23  First Financial Bankshares Inc.   10-Q        9/30/23   70:45M                                    Donnelley … Solutions/FA
 8/02/23  First Financial Bankshares Inc.   10-Q        6/30/23   70:51M                                    Donnelley … Solutions/FA
 5/03/23  First Financial Bankshares Inc.   10-Q        3/31/23   70:47M                                    Donnelley … Solutions/FA


17 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/12/23  First Financial Bankshares Inc.   8-K:1,2,9   1/06/23   11:288K                                   Donnelley … Solutions/FA
 1/11/23  First Financial Bankshares Inc.   8-K:5,7,9   1/09/23   12:352K                                   Donnelley … Solutions/FA
 8/10/22  First Financial Bankshares Inc.   8-K:5,9     8/09/22   11:299K                                   Donnelley … Solutions/FA
 7/29/22  First Financial Bankshares Inc.   8-K:5,9     7/26/22   11:740K                                   Donnelley … Solutions/FA
 8/02/21  First Financial Bankshares Inc.   10-Q        6/30/21   80:19M                                    Donnelley … Solutions/FA
 7/07/21  First Financial Bankshares Inc.   8-K:1,9     6/30/21   11:168K                                   Donnelley … Solutions/FA
 3/12/21  First Financial Bankshares Inc.   DEF 14A     4/27/21    1:2.4M                                   Donnelley … Solutions/FA
 5/01/20  First Financial Bankshares Inc.   8-K:5,9     4/28/20   11:242K                                   Donnelley … Solutions/FA
 4/03/20  First Financial Bankshares Inc.   8-K:5,8,9   4/03/20   12:296K                                   Donnelley … Solutions/FA
 9/20/19  First Financial Bankshares Inc.   8-K:1,7,9   9/19/19   12:865K                                   Donnelley … Solutions/FA
 7/30/19  First Financial Bankshares Inc.   10-Q        6/30/19   82:16M                                    Donnelley … Solutions/FA
 7/01/19  First Financial Bankshares Inc.   8-K:1,9     6/30/19    2:43K                                    Donnelley … Solutions/FA
 6/30/17  First Financial Bankshares Inc.   8-K:1,9     6/30/17    2:39K                                    Donnelley … Solutions/FA
 6/30/15  First Financial Bankshares Inc.   8-K:1,9     6/30/15    2:44K                                    Donnelley … Solutions/FA
 7/01/13  First Financial Bankshares Inc.   8-K:1,9     6/30/13    2:117K                                   Donnelley … Solutions/FA
 3/01/12  First Financial Bankshares Inc.   DEF 14A     4/24/12    1:534K                                   Donnelley … Solutions/FA
 1/07/94  First Financial Bankshares Inc.   8-A12G/A               4:53K                                    Donnelley Fin’l S… 03/FA
Top
Filing Submission 0000950170-23-003864   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 2:00:29.2pm ET